Media ECP Pharma Developing Innovative Drug Products for Neurological and Central Nervous System Diseases. March 22, 2022 ECP Pharma’s Path Forward Clearer After FDA’s Response To Pre-IND Submission On Its Neurological, CNS Diseases Drug Products | Business Wire. June 07, 2022 ECP Pharma Desarrolla Productos Farmacéuticos para Tratar Enfermedades Neurológicas y del Sistema Nervioso Central. June 28, 2022
